Cargando…

Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran

We decided to examine suspected samples of pneumonia outbreak caused by the new coronavirus SARS-CoV-2 and provide information about the mortality rate due to this infection in different age groups in Iran. In this descriptive-cross-sectional study, a total of 784 samples of naso/oropharyngeal swabs...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalantari, Hamidreza, Tabrizi, Aida Haji Hossein, Foroohi, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540192/
https://www.ncbi.nlm.nih.gov/pubmed/33047096
http://dx.doi.org/10.1016/j.genrep.2020.100910
_version_ 1783591154443354112
author Kalantari, Hamidreza
Tabrizi, Aida Haji Hossein
Foroohi, Fatemeh
author_facet Kalantari, Hamidreza
Tabrizi, Aida Haji Hossein
Foroohi, Fatemeh
author_sort Kalantari, Hamidreza
collection PubMed
description We decided to examine suspected samples of pneumonia outbreak caused by the new coronavirus SARS-CoV-2 and provide information about the mortality rate due to this infection in different age groups in Iran. In this descriptive-cross-sectional study, a total of 784 samples of naso/oropharyngeal swabs of suspected patients with COVID-19 symptoms who had referred to Imam Khomeini, Shahid Fayaz-Bakhsh and Modarres hospitals in Tehran from February 24, 2020 to March 24, 2020 were examined by RT-PCR method. The highest incidence of the disease was within the age group of 50–59 years, while the lowest rate was in the 0–9 years age group. The highest rate of positive samples in terms of COVID-19 among suspected individuals was for patients >80 years of age (89%) and the highest mortality rate was in the age range of 70–79 years (31%) and >80 years (30), respectively. In terms of recovery, the highest rate was in the 30–39 years age group (65.2%). Statistical analysis showed that mortality significantly increased in the age group of >60 years old and in fact, mortality was significantly associated with older ages. According to the results of the current study, the prevalence of COVID-19 in lower age (0–9 years old) is lower and mortality rate is higher in older ages as significant increase in mortality was observed in those aged >60 years old. However, further epidemiological studies on a larger study population in different regions of Iran are needed to explain the prevalence, clinical features, and course of the disease.
format Online
Article
Text
id pubmed-7540192
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-75401922020-10-08 Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran Kalantari, Hamidreza Tabrizi, Aida Haji Hossein Foroohi, Fatemeh Gene Rep Article We decided to examine suspected samples of pneumonia outbreak caused by the new coronavirus SARS-CoV-2 and provide information about the mortality rate due to this infection in different age groups in Iran. In this descriptive-cross-sectional study, a total of 784 samples of naso/oropharyngeal swabs of suspected patients with COVID-19 symptoms who had referred to Imam Khomeini, Shahid Fayaz-Bakhsh and Modarres hospitals in Tehran from February 24, 2020 to March 24, 2020 were examined by RT-PCR method. The highest incidence of the disease was within the age group of 50–59 years, while the lowest rate was in the 0–9 years age group. The highest rate of positive samples in terms of COVID-19 among suspected individuals was for patients >80 years of age (89%) and the highest mortality rate was in the age range of 70–79 years (31%) and >80 years (30), respectively. In terms of recovery, the highest rate was in the 30–39 years age group (65.2%). Statistical analysis showed that mortality significantly increased in the age group of >60 years old and in fact, mortality was significantly associated with older ages. According to the results of the current study, the prevalence of COVID-19 in lower age (0–9 years old) is lower and mortality rate is higher in older ages as significant increase in mortality was observed in those aged >60 years old. However, further epidemiological studies on a larger study population in different regions of Iran are needed to explain the prevalence, clinical features, and course of the disease. Published by Elsevier Inc. 2020-12 2020-10-07 /pmc/articles/PMC7540192/ /pubmed/33047096 http://dx.doi.org/10.1016/j.genrep.2020.100910 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kalantari, Hamidreza
Tabrizi, Aida Haji Hossein
Foroohi, Fatemeh
Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran
title Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran
title_full Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran
title_fullStr Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran
title_full_unstemmed Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran
title_short Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran
title_sort determination of covid-19 prevalence with regards to age range of patients referring to the hospitals located in western tehran, iran
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540192/
https://www.ncbi.nlm.nih.gov/pubmed/33047096
http://dx.doi.org/10.1016/j.genrep.2020.100910
work_keys_str_mv AT kalantarihamidreza determinationofcovid19prevalencewithregardstoagerangeofpatientsreferringtothehospitalslocatedinwesterntehraniran
AT tabriziaidahajihossein determinationofcovid19prevalencewithregardstoagerangeofpatientsreferringtothehospitalslocatedinwesterntehraniran
AT foroohifatemeh determinationofcovid19prevalencewithregardstoagerangeofpatientsreferringtothehospitalslocatedinwesterntehraniran